nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—Pain in arm—Lisinopril—dilated cardiomyopathy	0.0573	0.0644	CcSEcCtD
Estazolam—Ulcer—Spironolactone—dilated cardiomyopathy	0.0244	0.0274	CcSEcCtD
Estazolam—Apathy—Furosemide—dilated cardiomyopathy	0.0176	0.0197	CcSEcCtD
Estazolam—Flat affect—Furosemide—dilated cardiomyopathy	0.0174	0.0195	CcSEcCtD
Estazolam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0157	0.0177	CcSEcCtD
Estazolam—Gastritis—Spironolactone—dilated cardiomyopathy	0.0148	0.0166	CcSEcCtD
Estazolam—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0132	0.0148	CcSEcCtD
Estazolam—Laryngitis—Lisinopril—dilated cardiomyopathy	0.0131	0.0147	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0128	0.0144	CcSEcCtD
Estazolam—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.012	0.0135	CcSEcCtD
Estazolam—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.0109	0.0123	CcSEcCtD
Estazolam—Mental disability—Furosemide—dilated cardiomyopathy	0.0109	0.0122	CcSEcCtD
Estazolam—Photosensitivity—Furosemide—dilated cardiomyopathy	0.0104	0.0116	CcSEcCtD
Estazolam—Oliguria—Lisinopril—dilated cardiomyopathy	0.0102	0.0115	CcSEcCtD
Estazolam—Vascular purpura—Furosemide—dilated cardiomyopathy	0.0102	0.0114	CcSEcCtD
Estazolam—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00968	0.0109	CcSEcCtD
Estazolam—Thirst—Furosemide—dilated cardiomyopathy	0.00956	0.0107	CcSEcCtD
Estazolam—Neck pain—Lisinopril—dilated cardiomyopathy	0.00952	0.0107	CcSEcCtD
Estazolam—Purpura—Furosemide—dilated cardiomyopathy	0.00944	0.0106	CcSEcCtD
Estazolam—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00935	0.0105	CcSEcCtD
Estazolam—Malaise—Spironolactone—dilated cardiomyopathy	0.00908	0.0102	CcSEcCtD
Estazolam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00902	0.0101	CcSEcCtD
Estazolam—Photophobia—Lisinopril—dilated cardiomyopathy	0.00883	0.00992	CcSEcCtD
Estazolam—Discomfort—Spironolactone—dilated cardiomyopathy	0.00847	0.00952	CcSEcCtD
Estazolam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00829	0.00931	CcSEcCtD
Estazolam—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00789	0.00886	CcSEcCtD
Estazolam—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00778	0.00874	CcSEcCtD
Estazolam—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00736	0.00827	CcSEcCtD
Estazolam—Somnolence—Spironolactone—dilated cardiomyopathy	0.00731	0.00821	CcSEcCtD
Estazolam—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00727	0.00816	CcSEcCtD
Estazolam—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00718	0.00807	CcSEcCtD
Estazolam—Arthritis—Lisinopril—dilated cardiomyopathy	0.00703	0.00789	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00695	0.00781	CcSEcCtD
Estazolam—Diplopia—Lisinopril—dilated cardiomyopathy	0.00683	0.00767	CcSEcCtD
Estazolam—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00683	0.00767	CcSEcCtD
Estazolam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00677	0.00761	CcSEcCtD
Estazolam—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00677	0.00761	CcSEcCtD
Estazolam—Sweating—Furosemide—dilated cardiomyopathy	0.00672	0.00755	CcSEcCtD
Estazolam—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00654	0.00735	CcSEcCtD
Estazolam—Urticaria—Spironolactone—dilated cardiomyopathy	0.00653	0.00734	CcSEcCtD
Estazolam—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0065	0.0073	CcSEcCtD
Estazolam—Ataxia—Lisinopril—dilated cardiomyopathy	0.00642	0.00721	CcSEcCtD
Estazolam—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00611	0.00686	CcSEcCtD
Estazolam—Visual impairment—Furosemide—dilated cardiomyopathy	0.00607	0.00682	CcSEcCtD
Estazolam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00606	0.0068	CcSEcCtD
Estazolam—Gastritis—Lisinopril—dilated cardiomyopathy	0.00604	0.00679	CcSEcCtD
Estazolam—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00595	0.00669	CcSEcCtD
Estazolam—Asthma—Lisinopril—dilated cardiomyopathy	0.0059	0.00663	CcSEcCtD
Estazolam—Tinnitus—Furosemide—dilated cardiomyopathy	0.00587	0.00659	CcSEcCtD
Estazolam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00582	0.00653	CcSEcCtD
Estazolam—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00562	0.00632	CcSEcCtD
Estazolam—Malnutrition—Furosemide—dilated cardiomyopathy	0.00548	0.00616	CcSEcCtD
Estazolam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00544	0.00611	CcSEcCtD
Estazolam—Flatulence—Furosemide—dilated cardiomyopathy	0.0054	0.00607	CcSEcCtD
Estazolam—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00539	0.00605	CcSEcCtD
Estazolam—Weight increased—Lisinopril—dilated cardiomyopathy	0.00537	0.00603	CcSEcCtD
Estazolam—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00534	0.006	CcSEcCtD
Estazolam—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00527	0.00592	CcSEcCtD
Estazolam—Depression—Lisinopril—dilated cardiomyopathy	0.00525	0.00589	CcSEcCtD
Estazolam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00523	0.00587	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00522	0.00586	CcSEcCtD
Estazolam—Rash—Spironolactone—dilated cardiomyopathy	0.00518	0.00582	CcSEcCtD
Estazolam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00518	0.00582	CcSEcCtD
Estazolam—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00516	0.00579	CcSEcCtD
Estazolam—Headache—Spironolactone—dilated cardiomyopathy	0.00515	0.00579	CcSEcCtD
Estazolam—Sweating—Lisinopril—dilated cardiomyopathy	0.00504	0.00567	CcSEcCtD
Estazolam—Agitation—Furosemide—dilated cardiomyopathy	0.00504	0.00566	CcSEcCtD
Estazolam—Haematuria—Lisinopril—dilated cardiomyopathy	0.00502	0.00564	CcSEcCtD
Estazolam—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00496	0.00558	CcSEcCtD
Estazolam—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00494	0.00555	CcSEcCtD
Estazolam—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00491	0.00552	CcSEcCtD
Estazolam—Leukopenia—Furosemide—dilated cardiomyopathy	0.00491	0.00551	CcSEcCtD
Estazolam—Nausea—Spironolactone—dilated cardiomyopathy	0.00488	0.00549	CcSEcCtD
Estazolam—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00474	0.00532	CcSEcCtD
Estazolam—Hallucination—Lisinopril—dilated cardiomyopathy	0.0047	0.00528	CcSEcCtD
Estazolam—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00469	0.00527	CcSEcCtD
Estazolam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00456	0.00513	CcSEcCtD
Estazolam—Confusional state—Furosemide—dilated cardiomyopathy	0.00451	0.00507	CcSEcCtD
Estazolam—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00447	0.00502	CcSEcCtD
Estazolam—Tinnitus—Lisinopril—dilated cardiomyopathy	0.0044	0.00495	CcSEcCtD
Estazolam—Shock—Furosemide—dilated cardiomyopathy	0.0044	0.00494	CcSEcCtD
Estazolam—Flushing—Lisinopril—dilated cardiomyopathy	0.00438	0.00493	CcSEcCtD
Estazolam—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00432	0.00486	CcSEcCtD
Estazolam—Chills—Lisinopril—dilated cardiomyopathy	0.00424	0.00476	CcSEcCtD
Estazolam—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00422	0.00474	CcSEcCtD
Estazolam—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00411	0.00462	CcSEcCtD
Estazolam—Flatulence—Lisinopril—dilated cardiomyopathy	0.00405	0.00455	CcSEcCtD
Estazolam—Tension—Lisinopril—dilated cardiomyopathy	0.00404	0.00453	CcSEcCtD
Estazolam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00402	0.00451	CcSEcCtD
Estazolam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00399	0.00449	CcSEcCtD
Estazolam—Back pain—Lisinopril—dilated cardiomyopathy	0.00398	0.00447	CcSEcCtD
Estazolam—Somnolence—Furosemide—dilated cardiomyopathy	0.00398	0.00447	CcSEcCtD
Estazolam—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00395	0.00444	CcSEcCtD
Estazolam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00389	0.00437	CcSEcCtD
Estazolam—Tremor—Lisinopril—dilated cardiomyopathy	0.00385	0.00433	CcSEcCtD
Estazolam—Pain—Furosemide—dilated cardiomyopathy	0.00382	0.0043	CcSEcCtD
Estazolam—Constipation—Furosemide—dilated cardiomyopathy	0.00382	0.0043	CcSEcCtD
Estazolam—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00382	0.00429	CcSEcCtD
Estazolam—Malaise—Lisinopril—dilated cardiomyopathy	0.00371	0.00417	CcSEcCtD
Estazolam—Syncope—Lisinopril—dilated cardiomyopathy	0.00369	0.00414	CcSEcCtD
Estazolam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00369	0.00414	CcSEcCtD
Estazolam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00368	0.00414	CcSEcCtD
Estazolam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00366	0.00411	CcSEcCtD
Estazolam—Palpitations—Lisinopril—dilated cardiomyopathy	0.00363	0.00408	CcSEcCtD
Estazolam—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00361	0.00406	CcSEcCtD
Estazolam—Cough—Lisinopril—dilated cardiomyopathy	0.00359	0.00403	CcSEcCtD
Estazolam—Urticaria—Furosemide—dilated cardiomyopathy	0.00355	0.00399	CcSEcCtD
Estazolam—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00354	0.00397	CcSEcCtD
Estazolam—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00354	0.00397	CcSEcCtD
Estazolam—Myalgia—Lisinopril—dilated cardiomyopathy	0.0035	0.00393	CcSEcCtD
Estazolam—Chest pain—Lisinopril—dilated cardiomyopathy	0.0035	0.00393	CcSEcCtD
Estazolam—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0035	0.00393	CcSEcCtD
Estazolam—Anxiety—Lisinopril—dilated cardiomyopathy	0.00349	0.00392	CcSEcCtD
Estazolam—Discomfort—Lisinopril—dilated cardiomyopathy	0.00346	0.00389	CcSEcCtD
Estazolam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00342	0.00385	CcSEcCtD
Estazolam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00338	0.0038	CcSEcCtD
Estazolam—Oedema—Lisinopril—dilated cardiomyopathy	0.00336	0.00377	CcSEcCtD
Estazolam—Shock—Lisinopril—dilated cardiomyopathy	0.0033	0.00371	CcSEcCtD
Estazolam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0033	0.0037	CcSEcCtD
Estazolam—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00324	0.00364	CcSEcCtD
Estazolam—Asthenia—Furosemide—dilated cardiomyopathy	0.00321	0.00361	CcSEcCtD
Estazolam—Pruritus—Furosemide—dilated cardiomyopathy	0.00316	0.00356	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00306	0.00344	CcSEcCtD
Estazolam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00301	0.00339	CcSEcCtD
Estazolam—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00299	0.00336	CcSEcCtD
Estazolam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00298	0.00335	CcSEcCtD
Estazolam—Dizziness—Furosemide—dilated cardiomyopathy	0.00296	0.00332	CcSEcCtD
Estazolam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00295	0.00332	CcSEcCtD
Estazolam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00292	0.00328	CcSEcCtD
Estazolam—Constipation—Lisinopril—dilated cardiomyopathy	0.00287	0.00322	CcSEcCtD
Estazolam—Pain—Lisinopril—dilated cardiomyopathy	0.00287	0.00322	CcSEcCtD
Estazolam—Vomiting—Furosemide—dilated cardiomyopathy	0.00284	0.00319	CcSEcCtD
Estazolam—Rash—Furosemide—dilated cardiomyopathy	0.00282	0.00317	CcSEcCtD
Estazolam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00282	0.00317	CcSEcCtD
Estazolam—Headache—Furosemide—dilated cardiomyopathy	0.0028	0.00315	CcSEcCtD
Estazolam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00277	0.00311	CcSEcCtD
Estazolam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00274	0.00308	CcSEcCtD
Estazolam—Urticaria—Lisinopril—dilated cardiomyopathy	0.00267	0.003	CcSEcCtD
Estazolam—Nausea—Furosemide—dilated cardiomyopathy	0.00266	0.00298	CcSEcCtD
Estazolam—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00265	0.00298	CcSEcCtD
Estazolam—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00265	0.00298	CcSEcCtD
Estazolam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00247	0.00278	CcSEcCtD
Estazolam—Asthenia—Lisinopril—dilated cardiomyopathy	0.00241	0.00271	CcSEcCtD
Estazolam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00237	0.00267	CcSEcCtD
Estazolam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00222	0.00249	CcSEcCtD
Estazolam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00213	0.0024	CcSEcCtD
Estazolam—Rash—Lisinopril—dilated cardiomyopathy	0.00212	0.00238	CcSEcCtD
Estazolam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00211	0.00238	CcSEcCtD
Estazolam—Headache—Lisinopril—dilated cardiomyopathy	0.0021	0.00236	CcSEcCtD
Estazolam—Nausea—Lisinopril—dilated cardiomyopathy	0.00199	0.00224	CcSEcCtD
Estazolam—GABRR1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00194	0.0176	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00189	0.0172	CbGpPWpGaD
Estazolam—GABRR1—Ion channel transport—PLN—dilated cardiomyopathy	0.00188	0.0171	CbGpPWpGaD
Estazolam—GABRR2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00185	0.0168	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0018	0.0164	CbGpPWpGaD
Estazolam—GABRR2—Ion channel transport—PLN—dilated cardiomyopathy	0.0018	0.0163	CbGpPWpGaD
Estazolam—GABRG3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00152	0.0138	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—RYR2—dilated cardiomyopathy	0.0015	0.0136	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00148	0.0135	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00148	0.0135	CbGpPWpGaD
Estazolam—GABRG3—Ion channel transport—PLN—dilated cardiomyopathy	0.00148	0.0135	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00146	0.0133	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—PLN—dilated cardiomyopathy	0.00146	0.0133	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00142	0.0129	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00135	0.0123	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00128	0.0116	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00125	0.0113	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00125	0.0113	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00124	0.0113	CbGpPWpGaD
Estazolam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00122	0.0111	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00121	0.011	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00121	0.011	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.0012	0.0109	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00119	0.0108	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00119	0.0108	CbGpPWpGaD
Estazolam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00119	0.0108	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00117	0.0107	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00117	0.0106	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00117	0.0106	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00116	0.0106	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00116	0.0106	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00114	0.0104	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00114	0.0104	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00113	0.0103	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00111	0.0101	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0011	0.00998	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00109	0.00989	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00108	0.00984	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00105	0.0096	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00104	0.00943	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00102	0.00931	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000997	0.00907	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.000995	0.00906	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000938	0.00853	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000911	0.00829	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000894	0.00814	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00089	0.0081	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000879	0.008	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000877	0.00798	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000873	0.00795	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000857	0.0078	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000853	0.00777	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000841	0.00765	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00075	0.00682	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000749	0.00682	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.000728	0.00662	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000718	0.00654	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000715	0.0065	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000702	0.00639	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.000698	0.00635	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000698	0.00635	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000685	0.00624	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000685	0.00624	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000674	0.00613	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000673	0.00613	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000669	0.00609	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000657	0.00598	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000655	0.00596	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000655	0.00596	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000643	0.00585	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000625	0.00569	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000625	0.00569	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000609	0.00554	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000599	0.00545	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000581	0.00529	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000574	0.00523	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000529	0.00482	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000521	0.00474	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000515	0.00468	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000515	0.00468	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000507	0.00461	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000507	0.00461	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000479	0.00436	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000471	0.00429	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000445	0.00405	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000433	0.00394	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000433	0.00394	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000433	0.00394	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000431	0.00393	CbGpPWpGaD
Estazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000429	0.0039	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000425	0.00387	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000421	0.00383	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000421	0.00383	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000418	0.0038	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000415	0.00378	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000413	0.00376	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000413	0.00376	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000412	0.00375	CbGpPWpGaD
Estazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000409	0.00373	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000407	0.00371	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000406	0.0037	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000406	0.0037	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000404	0.00367	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000404	0.00367	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000403	0.00367	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000396	0.00361	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000396	0.00361	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000391	0.00356	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00039	0.00355	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000384	0.0035	CbGpPWpGaD
Estazolam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000382	0.00347	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000378	0.00344	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000375	0.00341	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000368	0.00335	CbGpPWpGaD
Estazolam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000364	0.00331	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000357	0.00325	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000356	0.00324	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000346	0.00315	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000346	0.00315	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000337	0.00307	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000332	0.00302	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000323	0.00294	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000322	0.00293	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000308	0.0028	CbGpPWpGaD
Estazolam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.0003	0.00273	CbGpPWpGaD
Estazolam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000295	0.00269	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000284	0.00258	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000276	0.00251	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000271	0.00246	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000266	0.00242	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000264	0.0024	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00026	0.00236	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000258	0.00235	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000253	0.00231	CbGpPWpGaD
Estazolam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000252	0.0023	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00025	0.00227	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000247	0.00225	CbGpPWpGaD
Estazolam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000245	0.00223	CbGpPWpGaD
Estazolam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000241	0.00219	CbGpPWpGaD
Estazolam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000237	0.00215	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000236	0.00215	CbGpPWpGaD
Estazolam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000235	0.00214	CbGpPWpGaD
Estazolam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000231	0.0021	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000227	0.00206	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000213	0.00194	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000207	0.00189	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000203	0.00185	CbGpPWpGaD
Estazolam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000202	0.00184	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.0002	0.00182	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000199	0.00181	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000195	0.00178	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000194	0.00177	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000191	0.00174	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000171	0.00155	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000163	0.00149	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000159	0.00144	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000156	0.00142	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000153	0.00139	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000152	0.00139	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000149	0.00136	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000136	0.00124	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000133	0.00121	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000131	0.00119	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000127	0.00115	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000104	0.00095	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000103	0.000936	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.79e-05	0.0008	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.54e-05	0.000777	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.38e-05	0.000763	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.24e-05	0.00075	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.18e-05	0.000745	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.04e-05	0.000731	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	7.23e-05	0.000658	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.02e-05	0.000639	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.8e-05	0.000619	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	6.15e-05	0.00056	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.67e-05	0.000152	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.63e-05	0.000148	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.47e-05	0.000133	CbGpPWpGaD
